5th Floor, Rajapushpa Summit
Nanakramguda Rd, Financial District, Gachibowli
Hyderabad, Telangana - 500008
The China Cardiovascular Devices Market is segmented by Device Type (Diagnostic and Monitoring Devices and Therapeutic and Surgical Devices).
2018 - 2026
The increasing incidence of cardiovascular diseases and the growing geriatric population are the most significant factors, driving market growth. According to a report by the United Nations Department of Economic and Social Affairs, more than 11% of China's Population were aged 65 years or over, in 2019. Furthermore, China’s population is aging at a faster rate than almost all other countries of Asia-Pacific, which is in part, due to the long run of China’s one-child policy and a dramatic increase in healthcare facilities.
The aging process is commonly associated with increased vascular rigidity and decreased vascular compliance. Elderly patients have a high risk of developing cardiovascular disorders, such as peripheral arterial disease (PAD), aortic disease, and venous thromboembolism (VTE). This is primarily due to age-related alterations in vascular structure and rigidity, further compounded by longer exposure to cardiovascular disease (CVD) risk factors. Furthermore, other factors, such as the rapid technological advances and increasing awareness among the population, are supplementing the market growth.
As per the scope of the report, the market is segmented into diagnostic and monitoring devices and therapeutic and surgical devices sub-segments. Moreover, the diagnostic and monitoring devices segment is further subdivided into an electrocardiogram (ECG), remote cardiac monitoring, and other diagnostic and monitoring devices. Similarly, the therapeutic and surgical devices segment is subdivided into cardiac assist devices, cardiac rhythm management device, catheter, grafts, heart valves, stents, and other therapeutic and surgical devices.
|By Device Type|
Report scope can be customized per your requirements. Click here.
To understand key trends, Download Sample Report
Several local players, along with global medical device manufacturers, operate in the Chinese market. Local players dominate in the stent, catheter, and graft segments. However, the quality of products from global companies is perceived as superior. Thus, the premium segment of the cardiovascular devices market is dominated by global manufacturers.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rapid Technological Advances to Boost the Market Growth
4.2.2 Growing Public Awareness and Government Initiatives
4.3 Market Restraints
4.3.1 Shortage of Skilled Medical Professionals
4.3.2 High Cost of Instruments and Procedures
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Device Type
5.1.1 Diagnostic and Monitoring Devices
220.127.116.11 Electrocardiogram (ECG)
18.104.22.168 Remote Cardiac Monitoring
22.214.171.124 Other Diagnostic and Monitoring Devices
5.1.2 Therapeutic and Surgical Devices
126.96.36.199 Cardiac Assist Devices
188.8.131.52 Cardiac Rhythm Management Device
184.108.40.206 Heart Valves
220.127.116.11 Other Therapeutic and Surgical Devices
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Boston Scientific Corporation
6.1.3 Mindray Medical International Limited
6.1.4 Edwards Lifesciences
6.1.5 WL Gore & Associates Inc.
6.1.6 Medtronic PLC
6.1.7 Lepu Medical Technology (Beijing) Co. Ltd
6.1.8 Terumo Corporation
6.1.9 Microport Scientific Corporation
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments